COMPASS Pathways Secures $285 Million Towards Psychedelics for Mental Health
August 21, 2023
No Comments
But will Biden follow the science?
Tag: COMPASS Pathways
Psilocybin Causes ‘Significant Reduction’ in Symptoms of Depression, Largest of its Kind Study Shows
May 24, 2022
No Comments
COMPASS Pathways psilocybin study shows a significant improvement in treatment-resistant depression symptoms.
COMPASS Pathways Secures $285 Million Towards Psychedelics for Mental Health
August 21, 2023
No Comments
But will Biden follow the science?
Psilocybin Causes ‘Significant Reduction’ in Symptoms of Depression, Largest of its Kind Study Shows
May 24, 2022
No Comments
COMPASS Pathways psilocybin study shows a significant improvement in treatment-resistant depression symptoms.
Subscribe to High Times
Get notified of our the latest cannabis news, exclusive brand deals, events updates and more!